Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer

3 Stocks to Help You Get Through Today's Market Fear

Instead of a Santa Claus rally, the market continues to experience volatility at the end of the year with uncertainties surrounding the reopening of the Chinese economy and a looming recession due to seemingly unending interest rate hikes. Given this backdrop, loading up on fundamentally strong stocks Walmart (WMT), Pfizer…

StockNews.com

2 COVID-19 Stocks That Are Still Strong Buys

Given that COVID-19 is here to stay for the foreseeable future, investors could still benefit from their investments in companies that saw record-breaking sales during the pandemic’s height because of the effectiveness of their products in fighting the virus. With the potential resurgence of COVID-19 in several countries, Pfizer (PFE)…

StockNews.com

Getting vaccinated this holiday season? Here’s how to stay up-to-date on your COVID shots

DALLAS — Staying on schedule with the COVID-19 vaccine can feel like chasing a moving target.

Tribune News Service

From analysis to the latest developments in health,
read the most diverse news in one place.

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

The Independent UK

Inside Google's black box ad empire

Reporters uncovered a multi-billion-dollar ad network containing manga piracy, porn, fraud and disinformation

Salon

Weekly Must-Read: Why China’s Exports Are in the Doldrums

Demand has fallen off in recent months in the country’s three biggest markets, though the reasons vary by region

Caixin Global

The world fears a new China COVID wave, ponders how to help Xi

Officials and global health experts outside China are anxiously watching a COVID-19 surge there, worried a nation of 1.4 billion people is inadequately vaccinated and may not have the healthcare tools to treat a wave of illness expected to kill more than one million people through 2023.

Reuters

Read news from The Economist, FT, and more,
with one subscription

Dr Kerryn Phelps reveals wife’s ‘devastating’ vaccine injury, calls for urgent COVID plan

Dr Kerryn Phelps has spoken out about her wife's "severe" reaction to the COVID jab as she warned about the direction of Australia's current handling of the pandemic.

The New Daily

'Have a safe as summer': Public health measures replaced by advice

A list of advice for avoiding Covid this summer provides a stark contrast to the broad public health messaging of a year ago, despite case numbers being much higher

Newsroom.co.nz

The 3 Safest Stocks to Buy in the Market Now

Along with an interest rate hike of 50 bps at the FOMC meeting last week, the Fed officials signaled to continue raising rates through next year, with no expectations to cut rates until 2024. The Fed’s hawkish stance and rising recessionary fears have dampened investor sentiment lately. Given the backdrop,…

StockNews.com

Coronavirus FAQ: Is Paxlovid the best treatment? Is it underused in the U.S.?

The drug is the most effective way to cut the risk of severe disease. It's heading to China now. Yet the drug is underused in some places. Why? And are there options if you're not a good candidate?

WEKU

RSV treatments for young children are lacking, but the record 2022 cold and flu season highlights the urgency for vaccines and other preventive strategies

For many parents, respiratory syncytial virus – or RSV – which has been causing record numbers of hospitalizations of children during the fall of 2022, may sound like a relatively new and unheard-of threat. But in fact, RSV is a common respiratory virus that circulates every fall and winter and…

The Conversation

Pfizer to sell Paxlovid in China as COVID cases surge

Pfizer Inc. cemented a deal first announced in March to sell its antiviral medication Paxlovid in China through a state-owned company, adding to supply of COVID treatments in the country that’s now facing a massive infection surge.

Tribune News Service

2 years after Kentucky’s first COVID-19 vaccines, doctors continue to urge people to get vaxxed

WEKU

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune

China has a new strategy for keeping official COVID numbers down during its reopening: Stop counting many new infections

With mandatory testing dropped, it can no longer accurately gauge the number of people who have COVID but don’t have symptoms, its National Health Commission said.

Salon

DeSantis demands COVID vax grand jury

Doctors "outraged" after DeSantis pushes investigation and truther panel to refute CDC public health guidance

The Conversation

Nasal vaccines promise to stop the COVID-19 virus before it gets to the lungs – an immunologist explains how they work

The Pfizer-BioNTech and Moderna mRNA vaccines have played a large role in preventing deaths and severe infections from COVID-19. But researchers are still in the process of developing alternative approaches to vaccines to improve their effectiveness, including how they’re administered. Immunologist and microbiologist Michael W. Russell of the University at…

The Guardian - AU

China says spread of Covid ‘impossible’ to track as infections soar in Beijing

Health officials cease recording asymptomatic cases as shortages of medical supplies and testing kits reported in wake of sudden end to strict Covid policy

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune

China finally approves an mRNA COVID vaccine—but only for some foreigners

Beijing's uneasy relationship with mRNA vaccines is all the more relevant as it begins to relax COVID restrictions.

Tribune News Service

Paxlovid has been free so far. Next year, sticker shock awaits

Nearly 6 million Americans have taken Paxlovid for free, courtesy of the federal government. The Pfizer pill has helped prevent many people infected with COVID-19 from being hospitalized or dying, and it may even reduce the risk of developing long COVID. But the government plans to stop footing the bill…

StockNews.com

3 High-Yield Dividend Stocks With Upside Potential Right Now

Amid the stock market chaos due to the Fed’s fight against inflation and recessionary concerns, dividend stocks are gaining traction. Fundamentally strong dividend stocks can provide protection and ensure stable income. So, high-yield dividend stocks Pfizer (PFE), BHP Group (BHP), and Caledonia Mining (CMCL), with significant upside potential, might be…

Fortune

COVID, flu, RSV: The benefits of advocating for boosters in the workplace–and how to go about it

The return to the office has turned into a superspreader event.

WEKU

The FDA clears updated COVID-19 vaccines for kids under age 5

The decision aims to better protect the littlest kids amid an uptick in COVID-19 cases around the country. The Centers for Disease Control and Prevention is expected to sign off soon.

Tribune News Service

Omicron-fighting COVID vaccine authorized for kids as young as 6 months

The omicron-fighting COVID-19 vaccine is now approved for children ages 6 months and older, the U.S. Food and Drug Administration said Thursday.

Los Angeles Times

Michael Hiltzik: Rescinding the military's COVID vaccine rule is the Democrats' dumbest compromise in the lame-duck session

If you need evidence that Congress is dominated by its stupidest members, look no further than the apparent agreement in the House to lift the requirement that members of the military be vaccinated against COVID-19.

1 … 31 32 33 34

People

Mangeet Kaur BounsMangeet

Sristi Suman Jayaswal

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.